PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsAdenosine
Adenosine
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
1300 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Coronary artery diseaseD003324—I25.1714201776130
Breast neoplasmsD001943EFO_0003869C50365125119120
Myocardial ischemiaD017202EFO_1001375I20-I2551218134488
SyndromeD013577——2646331787
NeoplasmsD009369—C803134311271
Coronary diseaseD003327——291593164
Parkinson diseaseD010300EFO_0002508G205131111140
AsthmaD001249EFO_0000270J4547361030
Myocardial infarctionD009203EFO_0000612I21—4331928
InfarctionD007238EFO_0009463——4331928
Show 99 more
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
LeukemiaD007938—C95649510—6154
Myeloid leukemia acuteD015470—C92.042547—595
Myeloid leukemiaD007951—C9240536—591
LymphomaD008223—C85.931587—488
RecurrenceD012008——38474—583
Lymphoid leukemiaD007945—C9134524—482
Myelodysplastic syndromesD009190—D4631506—481
B-cell chronic lymphocytic leukemiaD015451—C91.126485—474
Precursor cell lymphoblastic leukemia-lymphomaD054198——31404—471
PreleukemiaD011289——24402—463
Show 96 more
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
B-cell lymphomaD016393——1518——433
B-cell lymphoma marginal zoneD018442—C88.4917——427
Plasma cell neoplasmsD054219——1213——224
Myeloid leukemia accelerated phaseD015465——517——323
Burkitt lymphomaD002051—C83.7614——321
T-cell lymphomaD016399——514——420
Renal cell carcinomaD002292EFO_0000376—1015——118
Plasmablastic lymphomaD000069293—C83.3512——318
Large-cell lymphoma immunoblasticD016400——512——318
Large-cell lymphoma anaplasticD017728—C84.6512——317
Show 212 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
AnxietyD001007EFO_0005230F41.11———910
Anxiety disordersD001008EFO_0006788F41.11———89
Substance-related disordersD019966EFO_0003890F132———35
HyperemiaD006940EFO_0003822—1———34
AlcoholismD000437EFO_0003829F10.11———34
Magnetic resonance imagingD008279——1———34
Mental disordersD001523EFO_0000677F91.91———34
Second primary neoplasmsD016609——2———13
Post-traumatic stress disordersD013313EFO_0001358F43.11———23
Traumatic stress disordersD040921——1———23
Show 64 more
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Pathologic constrictionD003251——————88
StrokeD020521EFO_0000712I63.9————66
Metabolic syndromeD024821EFO_0000195E88.810————55
Cerebral palsyD002547—G80————44
HypertrophyD006984EFO_0002460—————44
Bone fracturesD050723EFO_0003931T14.8————44
PregnancyD011247EFO_0002950Z33.1————33
CoughD003371HP_0012735R05————33
Chronic coughD000096822——————33
OverweightD050177—E66.3————33
Show 295 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
No data
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
159,673 adverse events reported
View more details
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use